| Year |
Citation |
Score |
| 2018 |
Obermajer N, Urban J, Wieckowski E, Muthuswamy R, Ravindranathan R, Bartlett DL, Kalinski P. Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nature Protocols. 13: 335-357. PMID 29345636 DOI: 10.1038/Nprot.2017.130 |
0.322 |
|
| 2017 |
Budiu RA, Vlad AM, Nazario L, Bathula C, Cooper KL, Edmed J, Thaker PH, Urban J, Kalinski P, Lee AV, Elishaev EL, Conrads TP, Flint MS. Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model. Cancer and Clinical Oncology. 6: 12-24. PMID 28603578 DOI: 10.5539/Cco.V6N1P12 |
0.408 |
|
| 2016 |
Francis L, Guo ZS, Liu Z, Ravindranathan R, Urban JA, Sathaiah M, Magge D, Kalinski P, Bartlett DL. Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. Oncotarget. PMID 26956047 DOI: 10.18632/Oncotarget.7907 |
0.383 |
|
| 2013 |
Kalinski P, Muthuswamy R, Urban J. Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. Expert Review of Vaccines. 12: 285-95. PMID 23496668 DOI: 10.1586/Erv.13.22 |
0.356 |
|
| 2013 |
Helfer BM, Balducci A, Urban J, Butterfield L, Ahrens E, Kalinski P, Wesa A. Abstract B44: Enabling in vivo visualization of cellular therapies in the clinic: Maturation of αDC1 data sets. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B44 |
0.313 |
|
| 2011 |
Li J, O'Malley M, Urban J, Sampath P, Guo ZS, Kalinski P, Thorne SH, Bartlett DL. Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 650-7. PMID 21266959 DOI: 10.1038/Mt.2010.312 |
0.316 |
|
| 2010 |
Watchmaker PB, Berk E, Muthuswamy R, Mailliard RB, Urban JA, Kirkwood JM, Kalinski P. Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 591-7. PMID 20018619 DOI: 10.4049/Jimmunol.0902062 |
0.609 |
|
| 2009 |
Kalinski P, Urban J, Narang R, Berk E, Wieckowski E, Muthuswamy R. Dendritic cell-based therapeutic cancer vaccines: What we have and what we need Future Oncology. 5: 379-390. PMID 19374544 DOI: 10.2217/Fon.09.6 |
0.323 |
|
| 2009 |
Urban JA, Brugmann W, Winandy S. Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 182: 3955-9. PMID 19299690 DOI: 10.4049/Jimmunol.0802869 |
0.388 |
|
| 2009 |
Giermasz AS, Urban JA, Nakamura Y, Watchmaker P, Cumberland RL, Gooding W, Kalinski P. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunology, Immunotherapy : Cii. 58: 1329-36. PMID 19156413 DOI: 10.1007/S00262-008-0648-5 |
0.327 |
|
| 2009 |
Sheridan BS, Cherpes TL, Urban J, Kalinski P, Hendricks RL. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. Journal of Virology. 83: 2237-45. PMID 19073721 DOI: 10.1128/Jvi.01699-08 |
0.632 |
|
| 2008 |
Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Research. 68: 5972-8. PMID 18632653 DOI: 10.1158/0008-5472.Can-07-6818 |
0.378 |
|
| 2008 |
Watchmaker PB, Urban JA, Berk E, Nakamura Y, Mailliard RB, Watkins SC, van Ham SM, Kalinski P. Memory CD8+ T cells protect dendritic cells from CTL killing. Journal of Immunology (Baltimore, Md. : 1950). 180: 3857-65. PMID 18322193 DOI: 10.4049/Jimmunol.180.6.3857 |
0.623 |
|
| 2007 |
Nakamura Y, Watchmaker P, Urban J, Sheridan B, Giermasz A, Nishimura F, Sasaki K, Cumberland R, Muthuswamy R, Mailliard RB, Larregina AT, Falo LD, Gooding W, Storkus WJ, Okada H, et al. Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity. Cancer Research. 67: 10012-8. PMID 17942935 DOI: 10.1158/0008-5472.Can-07-1735 |
0.581 |
|
| 2004 |
Urban JA, Winandy S. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions. Journal of Immunology (Baltimore, Md. : 1950). 173: 4470-8. PMID 15383578 DOI: 10.4049/Jimmunol.173.7.4470 |
0.744 |
|
| Show low-probability matches. |